- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: cyclophosphamide, fludarabine , thymoglobulin
Total 4385 results
-
Cartesian TherapeuticsActive, not recruiting
-
NCIC Clinical Trials GroupCompleted
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)CompletedMyelodysplastic Syndromes | Leukemia | Myelodysplastic/Myeloproliferative DiseasesUnited States
-
National Cancer Institute (NCI)RecruitingHepatocellular Carcinoma | Hepatocellular Cancer | Metastatic Hepatocellular CarcinomaUnited States
-
Dana-Farber Cancer InstituteThe Leukemia and Lymphoma SocietyEnrolling by invitationAcute Myeloid Leukemia | Myelodysplastic Syndromes | Juvenile Myelomonocytic Leukemia | Myeloproliferative NeoplasmUnited States
-
Kite, A Gilead CompanyTerminatedMultiple Myeloma | Ovarian Cancer | Fallopian Tube Cancer | Non-Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal AdenocarcinomaUnited States
-
Cancer Research UKCompleted
-
The Netherlands Cancer InstituteTerminated
-
University of NebraskaGenzyme, a Sanofi CompanyUnknownLiver Transplantation | Liver Disease | ImmunosuppressionUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI); Genentech, Inc.; Biologics, Inc.CompletedLymphoma | LeukemiaUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI)Completed
-
Chimeric TherapiesCompletedMyelodysplastic Syndromes | Leukemia | Graft Versus Host DiseaseUnited States
-
Roswell Park Cancer InstituteNational Heart, Lung, and Blood Institute (NHLBI)CompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Myelodysplastic-Myeloproliferative DiseasesUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Adult Burkitt Lymphoma | Recurrent Mantle Cell Lymphoma | Recurrent Marginal Zone Lymphoma | Recurrent Small Lymphocytic Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Recurrent Chronic Lymphocytic Leukemia | Recurrent Follicular Lymphoma and other conditionsUnited States
-
Mayo ClinicRecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Abramson Cancer Center of the University of PennsylvaniaTerminatedFallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian CarcinomaUnited States
-
M.D. Anderson Cancer CenterCompleted
-
Masonic Cancer Center, University of MinnesotaRecruitingMyelodysplastic Syndromes | Fanconi Anemia | Dyskeratosis Congenita | Severe Aplastic Anemia | Bone Marrow Failure | T Cell Receptor Alpha/Beta Depletion | Telomere Biology DisorderUnited States
-
French Innovative Leukemia OrganisationNovartis; Schering SACompletedGOELAMS SA4 Study: the Role of Fludarabine in the Treatment of Acute Myeloid Leukemia in the ElderlyAcute Myeloid LeukemiaFrance
-
Shanghai Ming Ju Biotechnology Co., Ltd.Not yet recruitingLymphoma, Large B-Cell, Diffuse | High-grade B-cell Lymphoma | Follicular Lymphoma Grade 3B | Mediastinal B-Cell Diffuse Large Cell LymphomaChina
-
University Health Network, TorontoRecruitingLymphoma, Large B-Cell, DiffuseCanada
-
University Health Network, TorontoTakara Bio Inc.RecruitingRelapsed or Refractory Chronic Lymphocytic Leukemia | Relapsed or Refractory Small Lymphocytic Lymphoma | Relapsed or Refractory CD19+ B-cell LymphomaCanada
-
M.D. Anderson Cancer CenterRecruitingAdenocarcinoma | Pancreatic Cancer | Ovarian CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstitutePrecigen, IncRecruitingAcute Lymphoblastic Leukemia | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Triple Negative Breast Cancer MalignanciesUnited States
-
GlaxoSmithKlineTerminatedNeoplasmsGermany, United States, Netherlands, Canada, Australia, Sweden
-
GlaxoSmithKlineCompleted
-
Henan Cancer HospitalThe Beijing Pregene Science and Technology Company, Ltd.Unknown
-
TriStar HealthWithdrawn
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMetastatic Castration-resistant Prostate CancerUnited States
-
Juno Therapeutics, Inc., a Bristol-Myers Squibb...Bristol-Myers Squibb Services Unlimited CompanyRecruitingSystemic Lupus Erythematosus | Systemic Sclerosis | Idiopathic Inflammatory MyopathyUnited States, Belgium, France, Spain, Germany, Italy
-
Allogene TherapeuticsRecruitingAdvanced/Metastatic Clear Cell Renal Cell CarcinomaUnited States
-
Allogene TherapeuticsRecruitingRelapsed or Refractory Large B Cell Lymphoma, Relapsed or Refractory Chronic Lymphocytic Leukemia, Relapsed or Refractory Small Lymphocytic LymphomaUnited States, Spain, Canada, Australia, Italy
-
National University of MalaysiaGaia ScienceRecruitingRelapsed B Acute Lymphoblastic Leukaemia | Refractory B Acute Lymphoblastic LeukaemiaMalaysia
-
University Hospital HeidelbergRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Chronic Lymphocytic Leukemia | Diffuse Large B Cell Lymphoma | Acute Lymphoblastic Leukemia, Pediatric | Acute Lymphoblastic Leukemia, AdultGermany
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Large B Cell LymphomaUnited States, Belgium
-
National Cancer Institute (NCI)CompletedAdult T-Cell Leukemia (ATL)United States
-
The Second Affiliated Hospital of Henan University...Xuzhou Medical University; Xinqiao Hospital of ChongqingUnknownRecurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade 3 Follicular Lymphoma | Recurrent Mantle Cell Lymphoma | Hematopoietic/Lymphoid Cancer | Adult Acute Lymphoblastic Leukemia in Remission | B-cell Chronic Lymphocytic... and other conditionsChina
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Miltenyi Biotec, Inc.Completed
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)Not yet recruitingPlasma Cell Myeloma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnProgressive Disease | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Minimal Residual Disease | Recurrent Chronic Lymphocytic Leukemia | CD19 Positive | CD22...United States
-
SynthekineRecruitingFollicular Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | NHL | CLL/SLL | Large B-cell Lymphoma | Indolent B-Cell Non-Hodgkin LymphomaUnited States
-
Kite, A Gilead CompanyRecruitingRelapsed and/or Refractory B-cell LymphomaUnited States, Netherlands, United Kingdom, Germany
-
University of PennsylvaniaActive, not recruiting
-
Stanford UniversityActive, not recruitingLymphoma | B Cell Lymphoma | Acute Lymphoblastic Leukemia, PediatricUnited States
-
Allogene TherapeuticsActive, not recruitingRelapsed/Refractory Follicular Lymphoma | Relapsed/Refractory Large B Cell LymphomaUnited States
-
National Institutes of Health Clinical Center (CC)National Cancer Institute (NCI)TerminatedSkin Cancer | Metastatic MelanomaUnited States
-
Czech CLL Study GroupUnknownChronic Lymphocytic LeukemiaCzech Republic
-
PNP Therapeutics, Inc.CompletedHead and Neck CancerUnited States
-
M.D. Anderson Cancer CenterVion PharmaceuticalsCompletedHematologic MalignanciesUnited States